Physician profile
Matthew Fox
NPI 1861513541
$12,181.23
in general payments reported to CMS, 2019-2025
44 companies · $930 in 2025
The $930 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $436 · 2020: $312 · 2021: $8,731 · 2022: $561 · 2023: $627 · 2024: $585 · 2025: $930.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,060 · Education: $81.77.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,060.37 |
| Education | $81.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,476.26 | 2019-2024 | |
| Atricure, INC. | $1,340.15 | 2021-2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Aop Health US, LLC | $425.38 | 2025 | Rapiblyk |
| Astrazeneca Pharmaceuticals LP | $137.76 | 2021-2025 | Tagrisso |
| Merck Sharp & Dohme LLC | $127.46 | 2023-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Pulmonx Corporation | $126.03 | 2019 | |
| Allergan, INC. | $124.13 | 2022 | |
| Stryker Corporation | $118.74 | 2020-2023 | Spy-Phi System |
| Kls-Martin L.P. | $115.48 | 2021-2025 | |
| Smith+Nephew, INC. | $92.62 | 2022-2024 | Pico 7, Pico 14, Renasys Touch |
| Novartis Pharmaceuticals Corporation | $90.52 | 2019-2023 | |
| Ethicon INC. | $79.17 | 2020 | |
| Covidien LP | $78.22 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $65.15 | 2020-2025 | |
| Lsi Solutions INC | $62.29 | 2020-2024 | Cor-Knot |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $55.25 | 2024 | Assure Wcd |
| Biom'Up France Sas | $50.85 | 2020 | |
| Incyte Corporation | $49.27 | 2024 | Jakafi, Monjuvi, Pemazyre |
| Amgen INC. | $47.21 | 2019-2020 | |
| Baxter Healthcare | $45.33 | 2024-2025 | Preveleak, Perclot |
| Lilly USA, LLC | $36.34 | 2020 | |
| Celgene Corporation | $29.51 | 2019 | |
| Angiodynamics, INC. | $26.00 | 2023 | Angiovac |
| Teleflex LLC | $25.66 | 2023 | Quikclot |
| Davol INC. | $25.22 | 2023 | Arista Ah Flexitip |
| Erbe USA INC | $24.31 | 2023 | Erbe Vio3 Apc3 |
| Ethicon US, LLC | $23.56 | 2023 | Echelon Endopath |
| Werfen USA LLC | $23.44 | 2021 | |
| Stemline Therapeutics INC. | $23.04 | 2024 | Orserdu |
| Cerus Corporation | $20.77 | 2023 | Intercept Blood System For Platelets |
| Foundation Medicine, INC. | $19.32 | 2019 | |
| Pharmacosmos Therapeutics INC. | $18.92 | 2024 | Cosela |
| Mentor Worldwide LLC | $17.70 | 2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Jazz Pharmaceuticals INC. | $17.14 | 2020 | |
| Corcym INC | $16.23 | 2024 | Perceval |
| Zimmer Biomet Holdings, INC. | $16.10 | 2025 | A&E Medical / Sternalock Xp Rigid Fixation System |
| Edwards Lifesciences Corporation | $15.45 | 2021 | |
| Daiichi Sankyo INC. | $14.78 | 2022 | |
| Trevena, INC. | $14.03 | 2021 | |
| Biomerieux INC | $14.00 | 2024 | Vidas Nephrocheck |
| Olympus America INC. | $13.82 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.34 | 2021 | |
| Ambu INC. | $13.05 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $12.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Fox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.